Skip to content

Biodesix, Inc. BDSX Provision for Credit Losses

Provision for Credit Losses at other companies

Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$636K+101%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$1.19M-42.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$47K-97.7%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForLoanLeaseAndOtherLosses.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s provision for credit losses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s provision for credit losses?
Biodesix, Inc. (BDSX) reported provision for credit losses of $24K in Q1 2026.
How has Biodesix, Inc.'s provision for credit losses changed year-over-year?
Biodesix, Inc.'s provision for credit losses decreased by 76.2% year-over-year, from $101K to $24K.
What is the long-term trend for Biodesix, Inc.'s provision for credit losses?
Over 2 years (2023 to 2025), Biodesix, Inc.'s provision for credit losses has grown at a -39.8% compound annual growth rate (CAGR), from $497K to $180K.
What does provision for credit losses mean?
Non-cash provision for expected loan losses, added back in operating cash flow since it's a reserve build, not a cash payment.